OOIR: Observatory of International Research

Papers

(The TQCC of Movement Disorders is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?	321
Multimodal Imaging Investigation of the Dentato‐Thalamo‐Cortical Pathway in Friedreich's Ataxia	229
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials	159
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy	159
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers	116
	109
May Infographic	107
Movement Disorders: Volume 40, Number 6, June 2025	106
Movement Disorders: Volume 40, Number 2, February 2025	105
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease	105
John Michael Walshe (April 24, 1920–October 14, 2022)	99
Issue Information	94
In Memoriam Mahlon R. DeLong (1938–2024)	83
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism	82
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy	80
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property	77
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia	74
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure	73
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation	69
Substantia Nigra Elasticity Measurement Using Transcranial Shear Wave Elastography: A Potential Biomarker for Parkinson's Disease	66
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease	66
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease	66
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model	65
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 12	65
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia	65

Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank	63
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?	63
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism	63
Assessing Intronic Variable Number Tandem Repeat ( VNTR) Expansions of the HSF1	62
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals	60
A GJA1 Variant Triggers Earlier SPG4 Onset by Destabilizing Deubiquitinase	59
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in H	55
Biallelic Variants in SLC27A3 Cause a Complex Form of Neurodegeneration with Brain Iron Accumulati	54
Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies	53
Indirect Striatal Projection Neurons Drive a D2 Receptor‐Dependent Pathway to Dyskinesia and Dystonia	53
Bilateral Globus Pallidus Deep Brain Stimulation Improves Motor Function in ADCY5 ‐Related Disorde	52
Patients with Allan‐Herndon‐Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment	51
Friedreich's Ataxia in Colombia: A Population‐Based Study of Incidence and Socioeconomic Determinants	49
Brain–Computer Interface Improves Symptoms of Isolated Focal Laryngeal Dystonia: A Single‐Blind Study	49
Research Priorities on the Role of α‐ Synuclein in Parkinson's Disease Pathogenesis	49
Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor‐Related Disorder	48
Navigating Visual Challenges: How Parkinson's Disease Alters Cognitive Priorities in Visual Search	46
The Lows of High Reward: Choking Under Pressure	46
Compound Heterozygous Structural Variants in Cases with Unsolved PRKN ‐Associated Parkinson's Dise	46
Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations	46
In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN‐Related Parkinson's Disease	46
Author Index	45
Stress in Musicians with and Without Focal Dystonia Is Not Reflected in Limbic Circuit Activation	45
Substantiating the Short Burst Duration in Cortical Myoclonus	45
Functional Movement Disorders and Drug‐Induced Movement Disorders	45
Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”	45
A CGG Repeat Expansion in CSNK1E Associated wit	43
	42
Issue Information	42
Reply to: “Adult‐Onset Neurodegeneration in Nucleotide Excision Repair Disorders: More Common than Expected”	41
Genetic Determinants of Survival in Parkinson's Disease in the Asian Population	40
Lesion of the Subthalamic Nucleus Should Not be Labeled “Subthalamotomy”; A Plea for Anatomical Accuracy and Compliance with Historical Legacy	40
Thank you to Reviewers 2022	40
Issue Information	39
Obituary for Jan O. Aasly (1950–2022)	38
Movement Disorders: Volume 37, Number 9, September 2022	38
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and ¹⁸F‐Fluorodopa‐Positron Emission Tomography	37
Exploration of Neurodegenerative Diseases Using Long‐Read Sequencing and Optical Genome Mapping Technologies	37
	37
Erratum to “Paired deep brain stimuli elicit short‐term facilitation in globus pallidus interna and subthalamic nucleus”	36
AI, Technology, Telemedicine	36
Dystonia	36
Spinal Cord Stimulation Failed to Improve Parkinson's Disease Symptoms in Randomized Crossover Double‐Blinded Evaluation	36
Author Response to Comment on “Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations”	35
Plant‐Based Dietary Patterns and Parkinson's Disease: A Prospective Analysis of the UK Biobank	35
Genetic Variation Analysis of Essential Tremor: Insights from the China Essential Tremor Alliance Cohort	35
Novel In‐Frame FGF14 Deletion Causes Spinocerebellar Ataxia Type 27A: Clinical Response to Deep Brain Stimulation and 4‐Aminopyridine	35
[ ¹¹ C ]( R )‐	35
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease	35
STUB1 ( SCA48 )/	35

Neurodevelopmental Disorder and Cortical Myoclonus in ZMYM2 Deficiency	34
Re‐emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity	34
Movement Disorders Thanks Journal Reviewers from 2025	34
Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder	33
The Self‐Administered Screening Questionnaire for Parkinson's Disease‐Associated Psychosis (SASPAP)	32
Deciphering the Janus‐Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis	32
Issue Information	32
Issue Information	32
Parkinsonisms	31
August Infographic	31
February Infographic	31
Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy	31
Practically Defined Off‐State Dyskinesia Following Repeated Intraputamenal Glial Cell Line–Derived Neurotrophic Factor Administration	30
Reply to: “Early Onset Nonprogressive Generalized Dystonia Is Caused by Biallelic SHQ1 Variants”	30
Epigenetic Drug Effects in Levodopa‐Treated Patients with Parkinson's Disease	30
Digging into the Unknowns of the Human Genome Sequence: The T2T‐CHM13 Reference Assembly Release	30
Unusual Age‐Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia	30
Static Posture Instability as a Sensitive Biomarker for Motor Abnormalities in Pre‐ataxic Spinocerebellar Ataxia Type 3 Patients	29
Keyword Index	29
Neurodegeneration with Brain Iron Accumulation Disorders and Retinal Neurovascular Structure	29
Movement Disorders: Volume 40, Number 3, March 2025	29
Movement Disorders: Volume 38, Number 12, December 2023	29
Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid	28
Defining the Importance of Minor Hallucinations in Parkinson's Disease	28
Structural Alterations in the Gray Matter Volume in Rapid‐Onset Dystonia‐Parkinsonism	28
Issue Information	28
In Memoriam Gregor K. Wenning (1964–2024)	28
Sex and Racial/Ethnic Differences in End‐of‐Life Care Preferences in Persons with Parkinson's Disease and Related Disorders	28
Free‐Water Imaging in Friedreich Ataxia Using Multi‐Compartment Models	28
¹⁸F‐Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies	27
Corrections to “A Machine‐Learning Derived Huntington's Disease Progression Model: Insights for Clinical Trial Design”	27
Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson's Disease	27
Correction to “Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus”	27
GAA ‐ FGF14 Expansions and	27
Association between the Amplification Parameters of the α‐Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease	26
Education, History, Disparities, Other Topics	26
Diagnostic Value of Glycocalyx Shedding in Blood for Differentiating between Parkinson's Disease and Multiple System Atrophy	26
Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis	26
Low/High Multi‐Frequency Stimulation of the Subthalamic Nucleus Improves Verbal Fluency Maintaining Motor Control in Parkinson's Disease	26
Shared Genetics and Comorbid Genes of Amyotrophic Lateral Sclerosis and Parkinson's Disease	26
Ethnic Differences in Dystonia Prevalence and Phenotype	26
Genetic Determined Iron Starvation Signature in Friedreich's Ataxia	26
Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease	26
Comparison of Two α‐Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism	25
Prediction of Pathological Subthalamic Nucleus Beta Burst Occurrence in Parkinson's Disease	25
Pallidal Evoked Resonant Neural Activity as a Candidate Biomarker for Deep Brain Stimulation in Dystonia	25
Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic Review	25
Whole‐Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy	25
Clearing the Smoke: What Protects Smokers from Parkinson's Disease?	25
Potential Disease‐Modifying Effects of Ganglioside GM1 Pulse Treatment on Spinocerebellar Ataxia Type 3, a Parallel‐Group, Double‐Blind, Randomized, Controlled Trial	25
Essential Tremor Suppression with a Novel Anti‐Tremor Orthosis: A Randomized Crossover Trial	25
Subthalamic Nucleus Activity during Cognitive Load and Gait Dysfunction in Parkinson's Disease	25
Movement Disorders: Volume 38, Number 9, September 2023	24
Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's Disease	24
Unilateral Magnetic Resonance‐Guided Focused Ultrasound (MRgFUS) Pallidothalamic Tractotomy in Parkinson's Disease: Promising Results But Uncertain T	24
CAG Repeat Expansion in THAP11 Is Associated with a Novel Spinocerebellar Ataxia	24
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome	24
Reply to: “Refutation of the αSyn‐SAA‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD‐ISS])”	24
Levodopa Disrupts Activity Patterns and Encoding of Movement in Striatal Cholinergic Interneurons of Behaving Mice	24
Pain in Multiple System Atrophy: A Community‐Based Survey	24
Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review	24
Waveform‐Based Analysis of Head Tremor Using a Marker‐Less Tracking Algorithm with 2D ‐Video: Evaluation of Sinusoidality and Rhythmicity	24
February Infographic	24
Target‐Dependent Postoperative Weight Gain after Pallidothalamic Tractotomy versus Pallidotomy for Dystonia	24
COVID ‐19 Infection Enhances Susceptibility to Oxidative Stress–Induced Parkinsonism	24
Classification and Genotype–Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review	24
Issue Information	23
Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate Synthase	23
Automated Motor Tic Detection: A Machine Learning Approach	23
GNAO1 Haploinsufficiency: The Milder End of the GNAO1 Phenotypic Spectrum	23
Obituary for Professor Hiroshi Shibasaki	23
Learning to Have a Long‐Duration Response	23
Two London Memorials to “James Parkinson [1755–1824], Esq. Surgeon, Late of Hoxton‐Square”	23
September Infographic	23
Reply to: Heterogeneity of CSF1R‐RD: Genes, Environment, or Both?	23
	23
Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings	23
No Correlation between Plasma GPNMB Levels and Multiple System Atrophy in Chinese Cohorts	23
Beyond the Homunculus— SCAN ‐ AMN as a Shared Action‐Oriented Neural Substrate across Movement Dis	22
Reply to: Enhancing Clarity in Tremor Network Gene Expression Analysis	22

Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial	22
Investigating the Brain Mechanisms of Externally Cued Sit‐to‐Stand Movement in Parkinson's Disease	22
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study	22
Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease	22
Movement Disorders: Volume 39, Number 9, September 2024	22
Phenotypical Differentiation of Tremor Using Time Series Feature Extraction and Machine Learning	22
Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B	22
Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers	22
Proteomic Profiling in Dystonia: The Next Frontier for Pathophysiology Research and Biomarker Exploration	22
Reply to “Comments on ‘Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets’”	22
Glucocerebrosidase Target Engagement and Therapeutic Plasma and Cerebrospinal Fluid Levels After GT ‐02287 Administration in Healthy Volunteers	21
On‐Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial	21
The Global Parkinson's Disease Genetics ( GP2 ) Genome Browser	21
Blood‐Based α‐Synuclein Seeding—A New Era for Identifying Parkinsonian Syndromes	21
Diffusion Tensor Imaging‐Along the Perivascular‐Space Index Is Associated with Disease Progression in Parkinson's Disease	21
Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body Disease	21
Long‐Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia	21
The Concept of Motor Reserve in Parkinson's Disease: New Wine in Old Bottles?	21
	21
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels	21
Natural Killer Subset Changes and Vascular Endothelial Growth Factor‐A Plasma Profile in Progressive Supranuclear Palsy: The NKscape Study	21
Plasma Metabolomics Profiles in Prodromal and Clinical Parkinson's Disease	21
Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18‐Year Study	21
First Evidence for Disease‐Modifying Treatment of SLC20A2‐Related Primary Familial Brain Calcification	21
The Pain in Dystonia Scale (PIDS)—Development and Validation in Cervical Dystonia	20
	20
April Infographic	20
Movement Disorders: Volume 38, Number 11, November 2023	20
March Infographic	20
Keyword Index	20
	20
Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral Sclerosis	20
Prasinezumab: A Bayesian Perspective on Its Efficacy	20
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study	20
Reply to Letter to the Editor‐MDS‐23‐0498.R2/MDS‐24‐0318.R1	20
Issue Information	20
Circulating Extracellular Vesicles as a Potential Mediator of Synuclein Pathology in the Gut	20
Anodal Cerebellar Transcranial Direct Current Stimulation Reduces Motor and Cognitive Symptoms in Friedreich's Ataxia: A Randomized, Sham‐Controlled Trial	19
Bidirectional Interplay between Deep Brain Stimulation and Cognition in Parkinson's Disease: A Systematic Review	19
The Race to Salvage Glucocerebrosidase: Understanding Small‐Molecule Therapies for GBA1 ‐Associate	19
Respiratory Function in Friedreich's Ataxia	19
Pathophysiological Role of Primary Motor Cortex in Essential Tremor	19
A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP‐NET	19
Brain Imaging Phenotypes Associated with Polygenic Risk for Essential Tremor	19
Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell‐Derived A9 Dopaminergic Neurons	19
Reply to: “Unravelling the Complexity of VPS16 Splicing: Clinical Implications and Unresolved Ques	19
Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based Study	19
Erythrocytic α‐Synuclein and the Gut Microbiome: Kindling of the Gut‐Brain Axis in Parkinson's Disease	18
Comparative Study of Focused Ultrasound Unilateral Thalamotomy and Subthalamotomy for Medication‐Refractory Parkinson's Disease Tremor	18
Step Width Haptic Feedback for Gait Stability in Spinocerebellar Ataxia: Preliminary Results	18
Automated Quantification of Eye Tics Using Computer Vision and Deep Learning Techniques	18
The Impact of Calcitriol on Frataxin Levels in Friedreich's Ataxia Patients: Insights and Future Directions	18
Deep Brain Stimulation Improves Parkinson's Disease‐Associated Pain by Decreasing Spinal Nociception	18
Reply to “Prevalence of NOTCH2NLC and FMR1	18
Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study	18
Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?	18
Novel Variants in DCTN1 Associated with Perry Disease: A Case Series from a Chinese Parkinsonism C	18
Clinical Trials in GBA1 ‐Associated Parkinson's Disease: A Need for Molecular Classification	18
Autosomal Recessive Cerebellar Ataxias in Europe: Frequency, Onset, and Severity in 677 Patients	18
Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine Monkey Model of Parkinson's Disease	18
Catatonia: What Else Matters?	18
Atypical and Other Parkinsonisms	18
Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease	18
Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study ( iCARE ‐ PD	17
Sympathetic Shift and Insular Alteration: Unravelling the Link Between Anxiety and Heart Rate Variability in Parkinson's Disease	17
Surgery Imaging and Technology	17
Advancing Parkinson's Research: Considerations and Future Directions	17
No Association Between Rare TWNK Variants and Parkinson's Disease in European Cohorts	17
Functional Magnetic Resonance Imaging (f MRI) Signatures of Progression and Phenoconversion in Prodromal Synucleinopathies	17
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease	17
Genetic Analysis of GCA Repeats in the GLS Gene: Implications for Undiagnosed Ataxia and Spinocerebellar Ataxia 3 in Mainland China	17
Aggregation‐Seeding Forms of α‐Synuclein Are Not Detected in Acute Coronavirus Disease 2019 Cerebrospinal Fluid	17
Issue Information	17
Reply to: Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy	17
Globus Pallidus Internus (GPi) Neuromodulation is Not Effective in Unverricht–Lundborg Disease to Control Myoclonia	17
Dysautonomia Is Associated with Cognitive Fluctuation in Dementia with Lewy Bodies	17
The Dawn of Precision Medicine for Deep Brain Stimulation in Parkinson's Disease?	17
Movement Disorders: Volume 40, Number 7, July 2025	17
Top Movement Disorders Journal Reviewers from 2024	16
A GNAI1 Pathogenic Variant in a Case with GNAO1‐Isolated Dystonia: A Modifier of Disease Severity?	16
Transcranial Ultrasound Stimulation of Internal Globus Pallidus Region and Motor Cortex in Parkinson's Disease	16
Reply to: Comment on De Giorgis et al. “Randomized Phase 3 Study of Triheptanoin for Glut1 Deficiency Syndrome–Associated Paroxysmal Movement Disorders”	16
Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome	16
Neurodevelopmental Gene‐Related Dystonia‐Parkinsonism with Onset in Adults: A Case with NAA15 Variant	16
The CM ‐ aGPi Network in the Generation of Tics in Tourette Syndrome	16
Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis	16
Small Strokes, Big Impact: Excessive Mortality After Acute Ischemic Stroke in Parkinson's Disease	16
A 10‐Year Community‐Based Study of Leucine‐Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease	16
Disentangling the Connection Between Neurodevelopment and Neurodegeneration in Huntington's Disease	16
Reply to: “Letter to the Editor by Cao et al.”	16
Further Directions in Mindfulness‐Based Interventions for Tic Disorders	16
Comments on: “Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis”	16
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria	15
Bilateral Simultaneous Magnetic Resonance–Guided Focused Ultrasound Pallidotomy for Life‐Threatening Status Dystonicus	15
Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease	15